Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

THYRAGE · Resetting the THYRoid axis for prevention of AGE-related diseases and co-morbidities

H2020Status: CLOSED1 January 201630 June 2021EU funding €6,000,000Call H2020-PHC-2014-2015

We hypothesize that inappropriate thyroid hormone action in target cells is a common mechanism underlying susceptibility to age-related degenerative diseases and co-morbidities. Although regulation of systemic thyroid status is well understood and underpins treatment of common thyroid disease, it is only in the last decade that the importance of local regulation of thyroid hormone action in tissue development, homeostasis and repair has been identified. During evolution, this complex temporal and cell-specific regulation has been optimized for development and reproductive fitness but NOT for ageing. Humans with their exceptional longevity are thus exposed to a prolonged period of suboptimal local thyroid hormone action. Consistent with this, thyroid status is a continuous variable within the population that is related to fracture risk, muscle mass and cognitive decline. Moreover, in healthy longevity thyroid status is characterized by thyroid stimulating hormone in the upper half of the reference range. In these studies, we will determine how local regulation of thyroid hormone action controls tissue homeostasis and repair, whilst its dysregulation is a common mechanism underlying chronic disease development during ageing. We focus on osteoporosis, osteoarthritis, neurodegeneration and sarcopenia as paradigm age-related, degenerative disorders. Using cutting-edge technology, we will (i) identify thyroid hormone dependent biomarkers for disease susceptibility in bone, cartilage, central nervous system and skeletal muscle, (ii) manipulate cell-specific thyroid hormone action in these tissues and (iii) develop cell-type specific modulators of thyroid hormone action. THYRAGE integrates cross-disciplinary expertise from clinical and basic scientists, endocrinologists, neuroscientists, gerontologists, and industry-based peptide scientists. These studies will identify and validate novel strategies for prevention and treatment of chronic age-related degenerative disease.

Consortium · 8 organisations

coordinator

ACADEMISCH ZIEKENHUIS LEIDEN

NL · €1,680,410

thirdParty

BIOSYNTH BV

NL

participant

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE

UK · €1,410,151

participant

UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II

IT · €758,500

participant

HUN-REN KISERLETI ORVOSTUDOMANYI KUTATOINTEZET

HU · €749,980

participant

PEPSCAN THERAPEUTICS BV

NL · €601,875

thirdParty

MUSEUM NATIONAL D'HISTOIRE NATURELLE

FR

participant

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS

FR · €799,084

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.